BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3900303)

  • 21. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
    J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
    N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
    Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S
    Oncology; 1989; 46(3):150-4. PubMed ID: 2654792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis].
    Sawamura N; Funaki Y; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Yoshioka S; Sakurai M; Eguchi K
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):943-6. PubMed ID: 3885865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised cross-over trial comparing low-dose metoclopramide and chlorpromazine with high-dose metoclopramide in Chinese patients with advanced cancer receiving cisplatinum and 5-fluorouracil.
    Shiu W; Tsang V; Lam YM; Zacharia A; Martin WM
    Cancer Chemother Pharmacol; 1987; 20(3):259-62. PubMed ID: 3315286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.
    Aapro MS; Plezia PM; Alberts DS; Graham V; Jones SE; Surwit EA; Moon TE
    J Clin Oncol; 1984 May; 2(5):466-71. PubMed ID: 6539363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin.
    Pollera CF; Nardi M; Marolla P; Carlini P
    Cancer Chemother Pharmacol; 1987; 19(4):335-8. PubMed ID: 3297376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial.
    Tsavaris N; Tsaroucha-Noutsou E; Bacoyannis C; Mylonakis N; Valilis P; Kozatsani-Halividi D; Tsoutsos H; Droufakou S; Kosmidis P
    Oncology; 1992; 49(6):479-83. PubMed ID: 1465288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
    Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
    Dana BW; McDermott M; Everts E; Abdulhay G
    Am J Clin Oncol; 1987 Jun; 10(3):253-6. PubMed ID: 3296733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technology.
    Rhinehart SN; Dugan WM; Parashos PJ; Triplett WC; Minnick DJ; Fry MW
    Prog Clin Biol Res; 1986; 216():407-16. PubMed ID: 3523534
    [No Abstract]   [Full Text] [Related]  

  • 34. Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study.
    Roila F; Boschetti E; Tonato M; Basurto C; Bracarda S; Picciafuoco M; Patoia L; Santi E; Penza O; Ballatori E
    Am J Clin Oncol; 1991 Jun; 14(3):238-42. PubMed ID: 2031511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen.
    Meyer BR; O'Mara V; Reidenberg MM
    J Clin Oncol; 1987 Dec; 5(12):1994-7. PubMed ID: 3316518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
    Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasone.
    Kris MG; Pendergrass KB; Navari RM; Grote TH; Nelson AM; Thomas V; Ferguson BB; Allman DS; Pizzo BA; Baker TW; Fernando IJ; Chernoff SB
    J Clin Oncol; 1997 May; 15(5):2135-8. PubMed ID: 9164228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose dexamethasone and high-dose metoclopramide versus high-dose dexamethasone and sulpiride in the management of cisplatin-induced emesis.
    Rosenblatt E; Lev LM; Robinson E
    Oncology; 1988; 45(4):297-9. PubMed ID: 3387033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.
    Lee CW; Suh CW; Lee JS; Lee KH; Cho GY; Kim SW; Kim SH
    J Korean Med Sci; 1994 Oct; 9(5):369-75. PubMed ID: 7702784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
    Nagai H; Suga S; Horiuchi Y; Kyokane K; Miwa Y; Aoki Y; Yasue K; Noro T; Kamikawa R; Ninomiya E
    Gan No Rinsho; 1990 Jun; 36(7):791-6. PubMed ID: 2113110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.